ATE417851T1 - 7-iminoderivate von camptothecin mit antitumorwirkung - Google Patents

7-iminoderivate von camptothecin mit antitumorwirkung

Info

Publication number
ATE417851T1
ATE417851T1 AT04719039T AT04719039T ATE417851T1 AT E417851 T1 ATE417851 T1 AT E417851T1 AT 04719039 T AT04719039 T AT 04719039T AT 04719039 T AT04719039 T AT 04719039T AT E417851 T1 ATE417851 T1 AT E417851T1
Authority
AT
Austria
Prior art keywords
camptothecin
tumor effect
imino derivatives
imino
derivatives
Prior art date
Application number
AT04719039T
Other languages
German (de)
English (en)
Inventor
Sabrina Dallavalle
Sergio Penco
C Pisano
F Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE417851T1 publication Critical patent/ATE417851T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT04719039T 2003-03-17 2004-03-10 7-iminoderivate von camptothecin mit antitumorwirkung ATE417851T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/388,587 US7105492B2 (en) 1999-03-09 2003-03-17 Camptothecin derivatives having antitumor activity

Publications (1)

Publication Number Publication Date
ATE417851T1 true ATE417851T1 (de) 2009-01-15

Family

ID=33029646

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04719039T ATE417851T1 (de) 2003-03-17 2004-03-10 7-iminoderivate von camptothecin mit antitumorwirkung

Country Status (19)

Country Link
US (2) US7105492B2 (https=)
EP (1) EP1603919B1 (https=)
JP (1) JP4791355B2 (https=)
KR (1) KR101174112B1 (https=)
CN (1) CN100372855C (https=)
AR (1) AR043620A1 (https=)
AT (1) ATE417851T1 (https=)
AU (1) AU2004222044B2 (https=)
BR (1) BRPI0408380A (https=)
CA (1) CA2517450C (https=)
CY (1) CY1108890T1 (https=)
DE (1) DE602004018468D1 (https=)
DK (1) DK1603919T3 (https=)
ES (1) ES2319293T3 (https=)
PL (1) PL1603919T3 (https=)
PT (1) PT1603919E (https=)
SI (1) SI1603919T1 (https=)
TW (1) TWI341840B (https=)
WO (1) WO2004083214A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
US8975248B2 (en) * 2004-12-15 2015-03-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Combinations of therapeutic agents for treating cancer
US7291936B1 (en) * 2006-05-03 2007-11-06 Robson John H Submersible electrical power generating plant
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
WO2022140504A1 (en) * 2020-12-23 2022-06-30 Shanghai Ruotuo Biosciences Co., Ltd. Antibody-drug conjugates, pharmaceutical compositions, and therapeutic applications

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
DK0612248T3 (da) * 1991-11-15 2003-12-08 Smithkline Beecham Corp Præparat, der indeholder cisplatin og topotecan som antitumormiddel
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
IT1282673B1 (it) 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
IL127800A (en) 1996-08-19 2005-11-20 Bionumerik Pharmaceuticals Inc Highly lipophilic 7-substituted camptothecin derivatives and pharmaceutical compositions containing them
ATE216998T1 (de) 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Also Published As

Publication number Publication date
DE602004018468D1 (de) 2009-01-29
ES2319293T3 (es) 2009-05-06
HK1089160A1 (zh) 2006-11-24
PL1603919T3 (pl) 2009-06-30
AR043620A1 (es) 2005-08-03
EP1603919B1 (en) 2008-12-17
DK1603919T3 (da) 2009-03-09
WO2004083214A1 (en) 2004-09-30
US20040018988A1 (en) 2004-01-29
KR101174112B1 (ko) 2012-08-16
US7105492B2 (en) 2006-09-12
US7351714B2 (en) 2008-04-01
JP2006520807A (ja) 2006-09-14
CA2517450C (en) 2011-06-14
TW200504076A (en) 2005-02-01
CA2517450A1 (en) 2004-09-30
CN100372855C (zh) 2008-03-05
CY1108890T1 (el) 2014-07-02
EP1603919A1 (en) 2005-12-14
US20060167033A1 (en) 2006-07-27
SI1603919T1 (sl) 2009-04-30
PT1603919E (pt) 2009-02-16
JP4791355B2 (ja) 2011-10-12
CN1761668A (zh) 2006-04-19
AU2004222044A1 (en) 2004-09-30
TWI341840B (en) 2011-05-11
KR20050107756A (ko) 2005-11-15
AU2004222044B2 (en) 2010-02-25
BRPI0408380A (pt) 2006-03-21

Similar Documents

Publication Publication Date Title
CY2013027I2 (el) Νεα παραγωγα ινσουλινης
ATE216998T1 (de) Camptothecin-derivate mit antitumor-wirkung
DE602004020183D1 (de) Schrittmacher mit av-intervall-optimierung
IS7939A (is) Pýrasólpýridín afleiður
DK1594840T3 (da) Piperidin-benzensulfonamid-derivater
DE60327864D1 (de) Ballondissektor mit kanüle
DE602004004553D1 (de) Chinazolinderivate
DE602004022180D1 (de) Chinazolinderivate
NO20053782D0 (no) Behandling av kreft med 2-deoksyglukose
ATE478870T1 (de) Spiroindolinpiperidinderivate
DK1556385T3 (da) Heterocyclocarboxamid-derivater
DE60330372D1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
ATE438644T1 (de) Chinazolinderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
DK1606277T3 (da) Imidazol-4-yl-ethynyl-pyridinderivater
NO20055649D0 (no) Substituert dihydrokinazolin med antiviale egenskaper
DK2275439T3 (da) Hidtil ukendte insulinderivater
IS8180A (is) Nýjar besímídasólafleiður
EP1643987A4 (en) Podophyllotoxin DERIVATIVES
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
DE60321752D1 (de) Halterung mit rotationssymmetrischen Taschen
ATE423771T1 (de) Tetrahydrochinolinderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1603919

Country of ref document: EP